Loading...
Loading...
Among the 4 tracked institutional investors we monitor, SLN (SILENCE THERAPEUTICS PLC) is held with a combined value of $13.94M across 2,644,786 shares. The largest holder is CITADEL ADVISORS LLC with a position worth $6.57M (0.00% of their portfolio). 4 funds increased their holdings.
Total Institutional Value
$13.94M
Total Shares Held
2,644,786
Institutional Holders
4
| # | Fund | Value↓ | Portfolio % | Change |
|---|---|---|---|---|
| 1 | CITADEL ADVISORS LLC | $6.57M | 0.00% | +381.4% |
| 2 | MILLENNIUM MANAGEMENT LLC | $5.66M | 0.00% | +62.9% |
| 3 | BlackRock, Inc. | $1.08M | 0.00% | +179.9% |
| 4 | Point72 Asset Management, L.P. | $630.88K | 0.00% | +4.9% |
As of the latest SEC 13F filings, CITADEL ADVISORS LLC is the largest institutional holder of SLN with a position worth $6.57M, representing 0.00% of their portfolio. In total, 4 institutional investors hold SLN with a combined value of $13.94M.
Institutional investors hold $13.94M worth of SLN stock across 4 positions. The largest institutional holder is CITADEL ADVISORS LLC with $6.57M in holdings.
A 13F filing is a quarterly report required by the SEC from institutional investment managers with over $100 million in assets. It discloses their holdings in U.S. equities. For SLN, these filings reveal which major funds are accumulating or reducing positions, providing insights into institutional sentiment.
Get notified when hedge funds change their SLN positions.